Bunge Global SA BG
- Market cap
- $21.2B
- P/E
- 21.2×
Follow BG
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 46.08 | 63.87 | 51.13 | 47.26 | 29.00 | 62.07 | 80.41 | 87.87 | 76.38 | 67.40 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| 74.00 | 83.75 | 83.20 | 59.65 | 66.71 | 96.99 | 128.40 | 116.59 | 114.92 | 99.55 |
High Price
|
|||
| 32,000 | 31,000 | 31,000 | 24,000 | 23,000 | 22,000 | 23,000 | 23,000 | 23,000 | 34,000 |
Employees
|
|||
| 1 | 1 | 1 | 2 | 2 | 3 | 3 | 3 | 2 | 2 |
Revenue/Emp
|
|||
| 42,679 | 45,794 | 45,743 | 41,140 | 41,404 | 59,152 | 67,232 | 59,540 | 53,108 | 70,329 |
Revenue
|
|||
| 5.65% | 3.85% | 4.95% | 1.32% | 6.73% | 5.69% | 5.48% | 8.14% | 6.39% | 4.85% |
Gross Margin
|
|||
| 996 | 230 | 456 | (1,205) | 1,413 | 2,565 | 2,066 | 3,051 | 1,524 | 1,134 |
EBT
|
|||
| 2.33% | 0.50% | 1.00% | (2.93%) | 3.41% | 4.34% | 3.07% | 5.12% | 2.87% | 1.61% |
EBT Margin
|
|||
| 767 | 174 | 287 | (1,291) | 1,165 | 2,167 | 1,678 | 2,337 | 1,188 | 843 |
Net Income
|
|||
| 547 | 609 | 622 | 548 | 435 | 424 | 408 | 451 | 468 | 703 |
Depreciation
|
|||
| 305.19 | 326.25 | 324.49 | 290.76 | 294.28 | 419.47 | 452.10 | 400.12 | 377.89 | 426.13 |
Revenue/Sh
|
|||
| 5.01 | 0.89 | 1.64 | (9.34) | 7.71 | 13.64 | 10.51 | 14.87 | 7.99 | 4.91 |
Earnings/Sh
|
|||
| 3.19 | (14.07) | (8.97) | (5.71) | (25.13) | (20.52) | (37.31) | 22.23 | 13.52 | 5.11 |
Cash Flow/Sh
|
|||
| (5.41) | (4.72) | (3.50) | (3.70) | (2.59) | (2.83) | (3.73) | (7.54) | (9.79) | (10.44) |
Capex/Sh
|
|||
| (2.22) | (18.79) | (12.46) | (9.41) | (27.73) | (23.35) | (41.05) | 14.69 | 3.73 | (5.33) |
Free CF/Sh
|
|||
| 52.51 | 52.41 | 45.24 | 42.62 | 44.10 | 55.49 | 66.95 | 79.39 | 77.88 | 105.24 |
Book Value/Sh
|
|||
| 140 | 140 | 141 | 141 | 141 | 141 | 149 | 149 | 141 | 165 |
Shares
|
|||
| 14.74 | 76.39 | 34.26 | 0.00 | 8.64 | 6.82 | 9.08 | 6.82 | 9.62 | 16.44 |
PE Ratio
|
|||
| 0.24 | 0.21 | 0.16 | 0.20 | 0.22 | 0.22 | 0.21 | 0.25 | 0.21 | 0.21 |
PS Ratio
|
|||
| 1.54 | 1.43 | 1.32 | 1.52 | 1.67 | 1.85 | 1.43 | 1.28 | 1.00 | 0.85 |
PB Ratio
|
|||
| 0.32 | 0.29 | 0.27 | 0.31 | 0.39 | 0.31 | 0.26 | 0.29 | 0.26 | 0.39 |
EV/Sales
|
|||
| (43.64) | (5.09) | (7.12) | (9.62) | (4.14) | (5.54) | (2.91) | 7.95 | 26.44 | (31.18) |
EV/FCF
|
|||
| 446 | (1,975) | (1,264) | (808) | (3,536) | (2,894) | (5,549) | 3,308 | 1,900 | 844 |
Op' Cash Flow
|
|||
| (757) | (662) | (493) | (524) | (365) | (399) | (555) | (1,122) | (1,376) | (1,723) |
Capex
|
|||
| (311) | (2,637) | (1,757) | (1,332) | (3,901) | (3,293) | (6,104) | 2,186 | 524 | (879) |
FCF
|
|||
| 3,408 | 4,188 | 3,896 | 3,653 | 5,196 | 7,136 | 7,158 | 8,663 | 8,523 | 9,264 |
Working Cap'
|
|||
| 4,264 | 4,479 | 5,372 | 4,994 | 7,288 | 5,964 | 4,651 | 4,882 | 6,238 | 14,051 |
Total Debt
|
|||
| 3,330 | 3,878 | 4,983 | 4,674 | 6,936 | 5,062 | 3,547 | 2,280 | 2,927 | 12,708 |
Net Debt
|
|||
| 7,343 | 7,357 | 6,378 | 6,030 | 6,205 | 7,825 | 9,956 | 11,814 | 10,945 | 17,369 |
Sh' Equity
|
|||
| 3.82% | 0.66% | 1.22% | (7.01%) | 5.34% | 8.61% | 6.65% | 8.98% | 4.52% | 2.35% |
ROA
|
|||
| 6.25% | 1.82% | 4.64% | (4.72%) | 6.79% | 10.33% | 10.71% | 14.45% | 9.28% | 3.29% |
ROIC
|
|||
| 11.24% | 1.89% | 3.77% | (23.98%) | 20.65% | 32.32% | 18.84% | 20.61% | 9.99% | 5.76% |
ROE
|
|||
Bunge Global SA peers in Farm Products
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| TSN Tyson Foods, Inc. | $17.8B | 30.5× | Compare |
| ADM Archer Daniels Midland Company | $39.2B | 22.2× | Compare |
| CALM Cal-Maine Foods, Inc. | $3.2B | 10.2× | Compare |
| IBA Industrias Bachoco, S.A. de C.V. | $2.5B | 11.9× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| AGRO Adecoagro S.A. | $1.5B | 31.6× | Compare |
| DMC Del Monte Corporation | $1.4B | 42.7× | Compare |
| DOLE Dole PLC | $1.2B | 20.9× | Compare |
| VITL Vital Farms, Inc. | $460.2M | 0.0× | Compare |
BG metrics, ten years each
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
Bunge Global SA (BG) key facts
- Bunge Global SA (BG) is a Farm Products company in the Consumer Defensive sector, listed on the New York Stock Exchange.
- Bunge Global SA’s revenue for fiscal 2025 (year ended December 2025) was $70.3 billion, up 32.4% from fiscal 2024.
- As of September 25, 2026, BG traded at $109.00, a market capitalization of $21.2 billion.
- Bunge Global SA pays an annual dividend of $2.65 per share, a yield of 2.96%, with a payout ratio of 19.3%.
- Return on equity was 5.76% and debt-to-equity 0.88.
Bunge Global SA (BG) Latest News
22 Sep
ADM and Bunge posted strong Q2 2026 results, lifting full-year guidance as biofuels clarity and shifting grain flows boost margins. ADM’s Ag Services & Oilseeds operating profit rose 129% YoY to $867M; EPS $1.84, vs $0.93. CEO Juan Luciano raised full-year EPS guidance to $5.15-$5.60 on renewable volume obligations and a $250M net 45Z benefit. Bunge revenue surged 88% to $24.04B and Softseed Processing EBIT jumped to $255M from $14M as new capacity in Argentina, Canada, and Europe came online; 2026 EPS guidance lifted to $9.25-$9.75. A Trump-Xi summit could unlock soybean, corn, sorghum concessions, boosting ADM Ag Services and potentially shifting flows for Bunge via China-Australia ties and canola movements. Bunge trades at forward P/E ~10 with a ~$141.78 target; ADM offers a 53-year dividend growth streak but may be less upside if talks disappoint. Trade talks could reallocate agricultural flows, materially affecting ADM and Bunge's volumes and margins.
BG extended three unsecured revolving credit facilities totaling $8.8 billion, extending maturities to Oct 2027–Oct 2031. The move locks in longer-dated liquidity to fund working capital and large projects, reducing near-term refinancing pressure for a capital-intensive agribusiness. The near-term narrative still hinges on successful Viterra integration, while risks include biofuel policy uncertainty and heavy capital expenditure that could pressure free cash flow if returns underwhelm. In Q2 2026 BG posted $678 million net income and continued its US$2.70 billion share buyback, repurchasing 2,032,363 shares in the quarter. The liquidity plus buybacks shape a funding-versus-return balance. BG projects $100.1 billion in revenue and $3.8 billion in earnings by 2029, requiring ~7.5% annual revenue growth and about $3.1 billion more earnings from today’s $686 million. A $142 fair value is implied, about 26% upside; some analysts see more upside, despite integration and funding risks. Longer-dated, committed liquidity lowers refinancing risk and funds capital-intensive growth, materially affecting risk profile.
Chesterfield, Missouri-based Bunge Global SA (BG) is a $22.2 billion market-cap agribusiness spanning the farm-to-consumer food chain, with segments in Soybean Processing and Refining, Softseed Processing and Refining, Other Oilseeds Processing and Refining, and Grain Merchandising and Milling. BG slipped 16.5% from a 52-week high of $134.87 reached June 6. Over the past three months, the stock rose modestly but trailed the S&P 500’s 3.5% advance. In the last year, BG gained 42.2% while the SPX returned 16.5%. The shares have traded below their 200-day and 50-day moving averages this month, implying near-term bearish momentum. On Sept. 1, BG rose 4.2% after announcing the sale of two Brazilian sugarcane mills—Rio Vermelho and Nova Unialco—to COFCO International, to streamline assets. Relative to ADM, BG outperformed over the past year (ADM +35.3%). Eight analysts rate BG Strong Buy, with a mean target of $137.45 (about 22% upside). The author held no positions. Asset divestiture to COFCO International signals strategic focus and potential efficiency gains that could materially affect BG's trajectory.
18 Sep
Bunge Global SA lifts its 2026 EPS outlook as oilseed momentum offsets grain risks. Raising 2026 EPS guidance signals materially stronger earnings trajectory and positive investor sentiment.
Bunge Global SA benefits from oilseed market strength but faces integration risks that raise questions over its value as a buy. Oilseed strength and integration risks create moderate influence on Bunge's performance and investor sentiment.
20 Aug
Bunge Global SA posts surging earnings while facing mounting cost and capacity risks that prompt questions on whether DAR is a buy. Earnings growth is offset by cost and capacity pressures that may influence financial results without fully reshaping company trajectory.
Core earnings strengthen at Bunge Global SA amid a 12.8% weekly rally, prompting questions on whether the gains can persist. Strengthening core earnings point to moderately noticeable influence on financial performance and market sentiment.
18 Aug
Bunge Global SA emerges as the standout profitable stock with strong fundamentals, while two other stocks draw scrutiny over performance concerns. Positive spotlight on Bunge fundamentals can lift near-term investor sentiment and share price.
7 Aug
Bunge (BG) Q2 2026 earnings call transcript released covering financial results and outlook. Q2 earnings details and guidance can influence near-term market views on Bunge performance.
2 Aug
Bunge Global SA relies on synergies from the Viterra acquisition and share buybacks while assessing evolution of its capital strategy. Viterra synergies and buybacks point to moderate effects on Bunge's financial results and market stance.
1 Aug
Bunge Global SA Q2 results underscore strength of its global platform, progress on Viterra integration, and margin tailwinds that support an improved outlook. Viterra integration and margin tailwinds constitute major strategic and operational shifts likely to reshape Bunge's competitive position and performance trajectory.
30 Jul
Bunge Global SA raised its outlook but lowered guidance on select metrics. Mixed guidance adjustments can sway near-term investor views on Bunge's results without reshaping core strategy.
Bunge Global SA's Q2 earnings call highlighted growth from Viterra operations. Viterra growth highlights in Q2 earnings call point to moderate effects on Bunge's financial trajectory and sentiment.
29 Jul
Bunge Global S.A. released its Q2 2026 earnings call summary covering financial performance, operational updates, and forward-looking statements for the agribusiness company. Q2 earnings call details directly shape near-term stock valuation and strategic outlook for Bunge Global S.A.
Bunge Global SA posted strong EPS growth in its Q2 2026 earnings call alongside progress on strategic initiatives. Strong EPS growth and strategic advancements signal major positive shifts in financial trajectory and investor outlook.
Bunge Global SA reported Q2 results with focus on segment performance, cost management, and strategic initiatives amid commodity market volatility. Q2 earnings details may influence near-term investor views on operations but do not signal major strategic shifts.
Bunge Global SA posted Q2 earnings below estimates while sales rose year over year on higher volumes. Mixed quarterly results create moderate pressure on near-term stock sentiment without signaling structural change.
Bunge Global SA (BG) Q2 earnings results are compared to estimates with analysis of key metrics. Q2 earnings versus estimates and key metrics directly inform views on financial performance.
Bunge Global SA released its second quarter 2026 financial results. Quarterly earnings provide updated financial metrics that may shift near-term investor views on performance.
28 Jul
Bunge Global (BG) continues its Viterra integration but shares remain below fair value estimates. Viterra developments may lift near-term sentiment for BG without altering core trajectory.
27 Jul
Collagen growth and supportive renewable fuel policies drive gains for DAR with effects on Bunge Global SA operations and positioning. Supportive renewable fuel policies create moderate influence on Bunge's performance and market trajectory.
20 Jul
Morgan Stanley states Archer-Daniels-Midland benefits from stronger crush margins but Bunge offers more upside. Analyst note favoring Bunge upside versus ADM can lift investor sentiment toward BG shares.
12 Jul
Analysts lifted Bunge Global SA earnings outlook, triggering a 7.4% stock rise with discussion of subsequent developments. Analyst earnings forecast upgrades typically produce moderate short-term gains in stock price and sentiment.
11 Jul
Bunge Global SA integrates Viterra, expanding its global operations and reshaping its network. Viterra integration drives major strategic expansion and network reshaping for Bunge Global.
10 Jul
Bunge Global (BG) receives rating upgrade to Buy. Analyst upgrade to Buy can lift near-term sentiment and trading activity without altering core operations or long-term trajectory.
4 Jun
Bunge Global SA faces cash strain that raises dilution risks for shareholders despite valuation upside remaining in the stock. Cash strain and dilution risks can moderately affect Bunge's financial performance and investor sentiment without fundamentally redefining its trajectory.
9 May
Bunge Global resets operations after Viterra merger completion, drawing investor focus to its widening valuation gap versus peers. Post-merger reset exposes valuation gaps that could significantly alter investor sentiment and Bunge's market trajectory.
7 May
Bunge Global SA (BG) reports Q1 adjusted EPS of $1.83. Q1 adjusted EPS disclosure affects financial performance and short-term market sentiment.
1 May
Investors react positively to Bunge Global SA (BG) EPS upgrade driven by Viterra merger synergies and announcement of new share buyback program. EPS upgrade from Viterra synergies and new buyback signal major improvements in financial performance and boost long-term investor sentiment.
30 Apr
Bunge Global (BG) upgraded to Strong Buy by analysts, highlighting robust agribusiness performance, favorable margins, and undervaluation, signaling significant upside potential for the stock. Analyst upgrade to Strong Buy reflects strong confidence in BG's operational strength and valuation, poised to enhance investor sentiment and drive stock gains.